Christopher Van Tuyl
CIK: 0001779707
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Immunovant, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 7, 2026IMVT
Immunovant, Inc.
Sale(S)Direct1.3K shares at avg. $32.06$43K - Sep 23, 2026IMVT
Immunovant, Inc.
Sale(S)Direct2.8K shares at avg. $36.36$103K - Jul 8, 2026IMVT
Immunovant, Inc.
Sale(S)Direct63 shares at avg. $39.99$3K - Jul 8, 2026IMVT
Immunovant, Inc.
Sale(S)Direct1.1K shares at avg. $39.53$45K - Jun 26, 2026IMVT
Immunovant, Inc.
Sale(S)Direct2.8K shares at avg. $38.96$111K - Jun 26, 2026IMVT
Immunovant, Inc.
Exercise(M)Direct17.8K shares at avg. $15.20$271K - Jun 26, 2026IMVT
Immunovant, Inc.
Sale(S)Direct15K shares at avg. $38.19$572K - Jun 18, 2026IMVT
Immunovant, Inc.
Sale(S)Direct2.6K shares at avg. $35.39$93K - Apr 8, 2026IMVT
Immunovant, Inc.
Sale(S)Direct5.2K shares at avg. $24.83$128K - Apr 7, 2026IMVT
Immunovant, Inc.
Award(A)Direct41.3K shares- - Mar 18, 2026IMVT
Immunovant, Inc.
Sale(S)Direct2.9K shares at avg. $24.97$72K - Dec 18, 2025IMVT
Immunovant, Inc.
Sale(S)Direct8.5K shares at avg. $26.78$228K - Dec 18, 2025IMVT
Immunovant, Inc.
Sale(S)Direct2.3K shares at avg. $27.38$63K - Apr 1, 2025IMVT
Immunovant, Inc.
Award(A)Direct50.8K shares- - Dec 16, 2024IMVT
Immunovant, Inc.
Award(A)Direct110K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 7, 2026 | IMVT Immunovant, Inc. | Sale(S) | 1,327 | $32.06 | $42,544 | Direct |
| Sep 23, 2026 | IMVT Immunovant, Inc. | Sale(S) | 2,846 | $36.36 | $103,481 | Direct |
| Jul 8, 2026 | IMVT Immunovant, Inc. | Sale(S) | 63 | $39.99 | $2,519 | Direct |
| Jul 8, 2026 | IMVT Immunovant, Inc. | Sale(S) | 1,143 | $39.53 | $45,183 | Direct |
| Jun 26, 2026 | IMVT Immunovant, Inc. | Sale(S) | 2,842 | $38.96 | $110,724 | Direct |
| Jun 26, 2026 | IMVT Immunovant, Inc. | Exercise(M) | 17,824 | $15.20 | $270,925 | Direct |
| Jun 26, 2026 | IMVT Immunovant, Inc. | Sale(S) | 14,982 | $38.19 | $572,163 | Direct |
| Jun 18, 2026 | IMVT Immunovant, Inc. | Sale(S) | 2,634 | $35.39 | $93,217 | Direct |
| Apr 8, 2026 | IMVT Immunovant, Inc. | Sale(S) | 5,165 | $24.83 | $128,247 | Direct |
| Apr 7, 2026 | IMVT Immunovant, Inc. | Award(A) | 41,343 | - | $0 | Direct |
| Mar 18, 2026 | IMVT Immunovant, Inc. | Sale(S) | 2,877 | $24.97 | $71,839 | Direct |
| Dec 18, 2025 | IMVT Immunovant, Inc. | Sale(S) | 8,529 | $26.78 | $228,407 | Direct |
| Dec 18, 2025 | IMVT Immunovant, Inc. | Sale(S) | 2,284 | $27.38 | $62,536 | Direct |
| Apr 1, 2025 | IMVT Immunovant, Inc. | Award(A) | 50,787 | - | - | Direct |
| Dec 16, 2024 | IMVT Immunovant, Inc. | Award(A) | 109,956 | - | $0 | Direct |
1-15 of 15 transactions
About Van Tuyl Christopher
Van Tuyl Christopher (SEC CIK 0001779707) files insider reports with the SEC as Chief Legal Officer of Immunovant, Inc. (IMVT).
Signal8 holds 12 ownership filings by Van Tuyl Christopher (1 Form 3, 11 Form 4), filed between Dec 18, 2024 and Oct 9, 2026. Those filings report 15 transactions, from Dec 16, 2024 to Oct 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Van Tuyl Christopher's filings is in DURHAM, NC.
Recent filings by Van Tuyl Christopher
- Oct 7, 2026: Open-market sale of IMVT shares (Form 4, code S).
- Sep 23, 2026: Open-market sale of IMVT shares (Form 4, code S).
- Jul 8, 2026: Open-market sales of IMVT shares (2 lines, Form 4, code S).
- Jun 26, 2026: Open-market sale of IMVT shares (Form 4, code S).
- Jun 26, 2026: Option exercise of IMVT shares (Form 4, code M).
Other insiders filing for Immunovant, Inc. (IMVT)
- Girao Tiago, Chief Financial Officer
- Stout Jay S, Chief Technology Officer
- Gloria Melanie, Chief Operating Officer
- Venker Eric, Chief Executive Officer
- Pande Atul, Director
- Fromkin Andrew J., Director